• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌伴脑粟粒状和肺转移,伴棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶易位,用克唑替尼治疗:一例报告。

Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report.

机构信息

Medical Oncology Department, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice Cedex 2, France.

出版信息

Lung Cancer. 2012 Dec;78(3):282-4. doi: 10.1016/j.lungcan.2012.08.015. Epub 2012 Sep 19.

DOI:10.1016/j.lungcan.2012.08.015
PMID:22999080
Abstract

Few descriptions of miliary brain metastases have been reported. We report the case of an adenocarcinoma of the lung associated with metachronous miliary brain and lung metastases with an echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase (EML4-ALK) gene translocation. The patient was treated with crizotinib and showed a twelve-month progression-free survival. Clinicians should be attentive of the evolution of brain metastases with patients presenting EML4-ALK translocation.

摘要

鲜有关于脑多发性转移瘤的描述。我们报告了一例肺腺癌伴脑和肺多发性转移瘤的病例,该转移瘤存在棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶(EML4-ALK)基因易位。该患者接受了克唑替尼治疗,无进展生存期为 12 个月。对于存在 EML4-ALK 易位的患者,临床医生应注意其脑转移瘤的演变。

相似文献

1
Adenocarcinoma of the lung with miliary brain and pulmonary metastases with echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase translocation treated with crizotinib: a case report.肺腺癌伴脑粟粒状和肺转移,伴棘皮动物微管相关蛋白样 4-间变性淋巴瘤激酶易位,用克唑替尼治疗:一例报告。
Lung Cancer. 2012 Dec;78(3):282-4. doi: 10.1016/j.lungcan.2012.08.015. Epub 2012 Sep 19.
2
New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.间变性淋巴瘤激酶阳性非小细胞肺癌的新见解
Indian J Cancer. 2017 Jan-Mar;54(1):203-208. doi: 10.4103/ijc.IJC_72_17.
3
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.根据ALK融合变体的间变性淋巴瘤激酶(ALK)重排肺腺癌的临床结局
J Transl Med. 2016 Oct 19;14(1):296. doi: 10.1186/s12967-016-1061-z.
4
Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation.与克唑替尼治疗伴有EML4-ALK易位的非小细胞肺癌相关的视神经病变和失明。
J Clin Oncol. 2015 Feb 10;33(5):e25-6. doi: 10.1200/JCO.2013.49.1985. Epub 2014 Mar 10.
5
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study.更新的疗效和安全性数据以及 EML4-ALK 融合变体对全球 III 期 ALEX 研究中未经治疗的 ALK 阳性晚期非小细胞肺癌中阿来替尼疗效的影响。
J Thorac Oncol. 2019 Jul;14(7):1233-1243. doi: 10.1016/j.jtho.2019.03.007. Epub 2019 Mar 20.
6
Long-lasting response to crizotinib in brain metastases due to EML4-ALK-rearranged non-small-cell lung cancer.EML4-ALK重排的非小细胞肺癌脑转移患者对克唑替尼的持久反应。
BMJ Case Rep. 2013 Sep 10;2013:bcr-2013-200867. doi: 10.1136/bcr-2013-200867.
7
[Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement].伴有表皮生长因子受体(EGFR)突变和间变性淋巴瘤激酶(ALK)重排的肺腺癌
Rev Mal Respir. 2017 May;34(5):576-580. doi: 10.1016/j.rmr.2016.08.002. Epub 2016 Sep 17.
8
A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.携带有 EML4-ALK 融合基因的新型人肺腺癌细胞系。
Jpn J Clin Oncol. 2014 Oct;44(10):963-8. doi: 10.1093/jjco/hyu110. Epub 2014 Aug 28.
9
Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report.伴有KRAS突变和ALK重排的肺腺癌对克唑替尼有反应:病例报告
Int J Biol Markers. 2015 May 26;30(2):e254-7. doi: 10.5301/jbm.5000127.
10
Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?克唑替尼治疗下孤立性中枢神经系统进展:EML4-ALK 易位非小细胞肺癌的阿喀琉斯之踵?
Cancer Biol Ther. 2012 Dec;13(14):1376-83. doi: 10.4161/cbt.22255. Epub 2012 Sep 17.

引用本文的文献

1
Miliary brain metastases from lung adenocarcinoma as non-enhancing lesions on MRI: a case report and literature review.肺腺癌的粟粒性脑转移瘤在MRI上表现为无强化病变:一例报告及文献复习
Transl Cancer Res. 2021 Feb;10(2):1162-1168. doi: 10.21037/tcr-20-1898.
2
Isolated progression of miliary brain metastasis in a patient with stable lung adenocarcinoma successfully treated with whole-brain radiotherapy: A case report.一名肺腺癌病情稳定的患者发生孤立性粟粒性脑转移,经全脑放疗成功治疗:病例报告
eNeurologicalSci. 2021 Aug 30;25:100366. doi: 10.1016/j.ensci.2021.100366. eCollection 2021 Dec.
3
Alectinib for Miliary Lung Metastasis in -Positive Lung Adenocarcinoma.
阿来替尼用于ALK阳性肺腺癌的粟粒性肺转移
Onco Targets Ther. 2021 Apr 30;14:2911-2915. doi: 10.2147/OTT.S300229. eCollection 2021.
4
Imaging Pattern of Diffuse Intrapulmonary Metastases in Lung Cancer Was Associated with Poor Prognosis to Epidermal Growth Factor Receptor Inhibitors.肺癌中弥漫性肺内转移的影像学特征与表皮生长因子受体抑制剂的预后不良相关。
Cancer Manag Res. 2020 Nov 17;12:11761-11772. doi: 10.2147/CMAR.S261983. eCollection 2020.
5
Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report.ROS1重排肺腺癌的粟粒性肺转移:一例报告
Mol Clin Oncol. 2020 Jul;13(1):80-82. doi: 10.3892/mco.2020.2040. Epub 2020 May 4.
6
Adenocarcinoma of the Lung with Miliary Metastases and Primary Resistance Exon 20 Mutations.伴有粟粒性转移和原发性耐药外显子20突变的肺腺癌
Cureus. 2018 Oct 31;10(10):e3533. doi: 10.7759/cureus.3533.
7
Miliary lung metastases from non-small cell lung cancer with Exon 20 insertion: A dismal prognostic entity: A case report.伴有外显子20插入的非小细胞肺癌粟粒性肺转移:一种预后不良的疾病:病例报告
Mol Clin Oncol. 2018 Dec;9(6):673-676. doi: 10.3892/mco.2018.1730. Epub 2018 Oct 1.
8
Systemic treatment of non-small cell lung cancer brain metastases.非小细胞肺癌脑转移的全身治疗
Contemp Oncol (Pozn). 2016;20(5):352-357. doi: 10.5114/wo.2016.64593. Epub 2016 Dec 20.
9
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer.表皮生长因子受体(EGFR)突变状态对非鳞状非小细胞肺癌转移行为的影响。
Oncotarget. 2017 Jan 31;8(5):8717-8725. doi: 10.18632/oncotarget.14427.
10
Clinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases.来自真实世界的临床数据:克唑替尼在中国晚期ALK重排非小细胞肺癌及脑转移患者中的疗效
Oncotarget. 2016 Dec 20;7(51):84666-84674. doi: 10.18632/oncotarget.13179.